Medicare Budget and New Initiatives
Medicare has become a significant component of the federal budget, surpassing $1 trillion last year. By 2023, it accounted for 14% of federal expenditures, with projections suggesting this could rise to 18% by 2032. After a period of escalating costs, new strategies are beginning to emerge to curb this growth. One notably promising initiative is the Wasted and Inappropriate Services Reduction Model (WISeR), which draws inspiration from prior authorization techniques commonly used in the private sector.
Currently, Medicare Part B premiums are set at $185 per month, reflecting a 28% increase over the past five years. Among the 61 million Americans enrolled in Part B last year, around 12% were spending more than 10% of their annual income on premiums. It’s clear that this financial burden is becoming increasingly untenable.
In a fragmented and costly healthcare system, it’s impractical to keep expending resources on low-value care.
The WISeR initiative is set to roll out in several states, including Ohio, Texas, and Washington, and will mandate pre-approval for certain “low-value” services. Studies suggest that such services are often over-utilized, driving up costs and, in some cases, causing harm.
While some may view the idea of needing Medicare to evaluate treatments as additional bureaucracy, if implemented correctly, prior approval shouldn’t be a hindrance. Instead, it serves as a protection for patients, enhancing care quality and ensuring responsible use of both taxpayer and premium dollars.
The fundamental aim of WISeR is straightforward: reduce unnecessary treatments and redirect resources toward more effective, evidence-based care. Critics have raised concerns about potential delays and increased red tape, which should be monitored. However, these worries don’t fully dismiss the promise that prior authorization has to improve the safety, efficiency, and financial viability of American healthcare.
Prior authorization directly tackles some of the most pressing issues in healthcare. Billions are wasted each year on low-value services. A recent survey highlighted that just 47 of these services cost Medicare more than $4 billion annually — funds that could be allocated to more beneficial uses.
This waste is also apparent in the private insurance arena. Unnecessary imaging tests and preferences for brand-name drugs over generics contribute to inflated premiums. Effective use of prior authorization could help minimize this waste, aligning coverage more closely with medical needs and best practices. Research from the University of Chicago indicates that Medicare’s prescription drug preauthorization rules lead to net savings after accounting for administrative expenses.
Take, for example, Medicare Part B’s coverage of skin substitutes for wound care. A report from the Office of Inspector General noted that expenditures on these items have soared past $10 billion annually in recent years, whereas Medicare Advantage plans, which utilize prior authorization, have managed to keep costs significantly lower for the same treatments.
Prior authorization is vital for promoting evidence-based medicine, as it helps eliminate outdated practices and discourages overtreatment. Health plans consistently assert that it aligns medical care with established clinical guidelines, especially where misuse is common.
Of course, it’s essential that the systems are designed thoughtfully. A functional prior authorization process needs to be transparent, responsive, and grounded in sound clinical evidence. Collaboration between care providers and decision-makers is crucial, and there should be an uncomplicated appeal process. Both public and private payers must also be accountable for inappropriate denials and delays that could harm patients.
When executed properly, prior authorization offers a more effective alternative to the current “pay-and-chase” model, where Medicare pays upfront and seeks to reclaim erroneous payments afterwards.
This model is already functioning successfully in the private sector and can be applied effectively within Medicare as well.
It’s imperative for public and private payers to responsibly manage their expenditures, regardless of whether funds come from taxpayers or policyholders. In a costly and fragmented system like ours, perpetually writing blank checks for subpar care simply isn’t feasible. With careful implementation, prior authorization can ensure coverage aligns with medical necessities, enhancing care value while keeping costs sustainable.
